
Advertise on podcast: Innovators
Rating
5from
This podcast has
77 episodes
Language
EnglishPublisher
Harris Search AssociatesExplicit
No
Date created
2017/08/07
Latest episode
2026/11/03
Average duration
33 min.
Release period
109 days
Description
The Innovators podcast, a product of Harris Search Associates, features interesting conversations with global thought leaders in the areas of higher education and research, engineering, technology, and the health sciences and provides our listeners an opportunity to benefit from lessons learned from the national leaders changing the landscape of innovation and discovery.
Unlock Innovators podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from Innovators podcast
The Health of American Public Health: Making the Case
2026/11/03
Cathy J. Bradley, PhD, is the Dean of the Colorado School of Public Health and the Deputy Director of the University of Colorado Cancer Center. A health economist, she holds the Paul A. Bunn, Jr. Endowed Chair in Cancer Research. Prior to joining the University of Colorado, Dr. Bradley served as the founding Chair of the Department of Healthcare Policy and Research at the Virginia Commonwealth University School of Medicine.
Dr. Bradley earned her bachelor's degree from Old Dominion University, a Master of Public Administration, and a PhD in Health Policy and Administration from the University of North Carolina Gillings School of Public Health.
Her research focuses on the intersection of work, health insurance, and cancer, examining how individuals and families navigate employment decisions when faced with costly and complex cancer treatment. Much of her work explores why many patients remain employed to maintain employer-based health insurance despite significant treatment and recovery needs, and how these choices affect caregivers and household financial stability. Within this scope, Dr. Bradley emphasizes policies aimed at reducing health disparities and financial burden for populations facing these difficult trade-offs. She is also an expert in Medicaid policy and the use of large administrative datasets to study health disparities.
Since 1998, Dr. Bradley has been continuously funded as a principal investigator by the National Institutes of Health and has received additional support from the American Cancer Society, the Commonwealth Fund, and other state and international agencies. She has served on national advisory committees, including the National Academies of Sciences, Engineering, and Medicine National Cancer Policy Forum, and currently serves on the Patient-Centered Outcomes Research Institute (PCORI) Methods Committee. Dr. Bradley has received numerous honors recognizing her leadership, scholarship, and contributions to health policy research.
INNOVATORS is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on INNOVATORS do not necessarily reflect the views of the interviewee's institution or organization.*
Bright Lights in Tennessee: UT Knoxville Recruits World-Class Researchers
2026/03/10
Donde Plowman was appointed Chancellor of the University of Tennessee, Knoxville, in 2019, having previously served on the faculty of business, and as Executive Vice Chancellor and Chief Academic Officer of the University of Nebraska, Lincoln.
She earned her doctorate in strategic management from the University of Texas at Austin, a master's in education from the University of North Texas, and a bachelor's degree in English from Southern Methodist University.
Chancellor Plowman discusses how Tennessee's flagship public university is pursuing an aggressive strategy in close alignment with the State's priorities, including efforts to recruit outstanding scholars and researchers to join UT Knoxville.
INNOVATORS is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on INNOVATORS do not necessarily reflect the views of the interviewee's institution or organization.*
Independent Research Institutes, Science and Cuts to Federal Support of Research
2025/12/30
Hermann Haller, MD President, Professor, MDI Biological Laboratory; Professor, Department of Nephrology and Hypertension, Hannover Medical School
Haller received his medical degree from the Free University of Berlin and completed his postdoctoral work at Yale University. He has published more than 700 peer-reviewed articles, holds six world-wide patents and has founded four biotech companies. He has received many honors and awards and serves on numerous advisory boards, including those of Bayer, Boehringer Ingelheim, Genzyme and Novo Nordisk. In addition to his position at the MDI Biological Laboratory, he is also a full professor of medicine and former chairman of the Division of Nephrology at the Hannover Medical School in Germany.
INNOVATORS is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on INNOVATORS do not necessarily reflect the views of the interviewee's institution or organization.*
The Governments' Role in Higher Education: A Brief Oral History (with Richard L. McCormick, PhD, President Emeritus, Board of Governors and Professor of History and Education at Rutgers University)
2025/11/18
Federal and state governments play significant roles in both public and private universities. The federal role in research is, at once, old enough to now span three-plus generations and yet recent enough that many people—ironically, those who rely on it most—are unaware of its origins. Recent actions by the federal government to cut billions of dollars from previously-approved research grants to universities, academic medical centers, and independent research institutes came as a shock to many, partly because they had assumed the process to be more or less engrained in law and policy and one of the ways by which research was funded.
Richard McCormick—three-time president of major research universities and an historian—offers a clear and compelling account of how the federal role in research began during World War II and evolved over the decades that followed. In today's INNOVATORS, he presents that historical portrait and, in doing so, suggests that recent shifts in federal policy may be less surprising than some have expressed, as they are, at least in part, in keeping with the public's changed and changing broader understanding and appreciation of higher education.
This is the second in a year-long series of INNOVATORS podcasts that began with the commentary of Daniel Linzer on the more prominent features of support for scientific and biomedical research. In the next podcast, the federal role of support for research in independent research institutes is examined.
INNOVATORS Guest: Richard L. McCormick, PhD, President Emeritus, Board of Governors and Professor of History and Education at Rutgers University
Federal Support for Scientific and Biomedical Research (with Daniel Linzer, PhD, President Emeritus, Research Corporation for Science Advancement)
2025/09/30
Dr. Daniel Linzer retired as President Emeritus of the Research Corporation for Science Advancement in July of this year after eight years of leadership. He joined RCSA from Northwestern University where he was on the faculty as professor of molecular biosciences and served as Provost for a decade following stints as dean and associate dean of arts and sciences.
Dr. Linzer earned his doctorate from Princeton and his undergraduate degree from Yale and was a post-doctoral fellow at the Johns Hopkins University School of Medicine. During his career, his research and teaching were recognized and awarded by the Searle Scholars Award, the American Cancer Society Faculty Research Award, and the Northwestern Alumni Association Excellence in Teaching Award.
His research on the P53/TP 53 gene was groundbreaking since it is a tumor suppression gene and therefore is fundamental to understanding cancer and a person's predisposition to cancer. His work led to discoveries identifying hormones that influence cellular development.
Innovation in Funding Research (with Kevin Byrne, MBA, President & CEO, The University Financing Foundation)
2025/07/22
Kevin Byrne is the President & CEO of TUFF, recognized for his innovative solutions to capital challenges faced by institutions. He specializes in non-traditional public-private partnerships and real estate financing for university research parks and innovation districts. Kevin holds an MBA with honors from the Wharton School and graduated with honors from Furman University, where he now serves as Chairman of the Board of Trustees. He has served as President of the Association of University Research Parks and is involved in various community and advisory boards, including Young Life Metro Atlanta and the Boy Scouts of America.
The State of Biomedical Research (with Claire Pomeroy, MD, MBA, President of the Albert and Mary Lasker Foundation)
2024/10/08
Dr. Claire Pomeroy is a distinguished physician, educator, and advocate for healthcare reform. With an undergraduate and medical degree from the University of Michigan and an MBA from the University of Kentucky, Dr. Pomeroy has served on the medical faculties of the University of Kentucky, the University of Minnesota, and UC Davis, where she became the dean of the School of Medicine and is now professor emeritus. Her career has focused on addressing healthcare disparities, advocating for a proactive, preventative healthcare system that ensures equitable care for all populations, especially the underserved.
Since June 2013, Dr. Pomeroy has been the president of the Albert and Mary Lasker Foundation, where she provides strategic leadership in promoting medical research and public advocacy. The Lasker Foundation is renowned for its prestigious annual awards that recognize groundbreaking achievements in medical science and public service. Under her leadership, the foundation continues to inspire scientific innovation and discovery worldwide.
Her life experiences, including overcoming a difficult childhood in the foster care system, have shaped her deep commitment to healthcare equality and compassion for disadvantaged populations. Dr. Pomeroy's unique blend of scientific expertise, leadership, and advocacy continues to impact the field of medical research and healthcare reform.
Opioids in America: A Crisis Without End (with Jennifer Sharpe Potter, PhD, MPH, Vice President for Research; Professor of Psychiatry and Behavioral Sciences at the University of Texas Health San Antonio)
2024/09/03
In this episode of INNOVATORS, Dr. Jennifer Potter's talk offers an in-depth analysis of the enduring and deadly opioid crisis in America, exploring the factors that have sustained this epidemic for decades and assessing recent developments in overdose trends to understand their implications for the future.
Originally from Canada, Dr. Potter earned her undergraduate degree from Queen's University, followed by a Master of Public Health from Emory University and a Ph.D. in Clinical Psychology from the University of Georgia. She completed her pre-doctoral internship and post-doctoral research fellowship at Harvard Medical School and McLean Hospital, where she worked until joining the University of Texas Health Science Center at San Antonio. At UT Health San Antonio, Dr. Potter rose through the academic ranks to Full Professor and was appointed Vice President for Research in 2021.
The Successful Start of a New Medical School: A Conversation with Mark A. Schuster, MD, PhD (Founding Dean and CEO; Professor, Health Systems Science at Kaiser Permanente Bernard J. Tyson School of Medicine)
2023/10/17
In recent years, a number of new medical schools – both allopathic and osteopathic – have launched and still more are in preparation.
In 2017 Kaiser Permanente announced the appointment of Dr. Mark A. Schuster of Harvard Medical School and Boston Children's Hospital as the founding dean of the Kaiser Permanente Bernard J. Tyson School of Medicine. A renowned figure in pediatric, adolescent, and family health; family leave; obesity prevention; sexual and gender minority health; bullying; and quality of health care, Schuster pledged to build the new school "from the ground up" on evidence-based best practices. Three years later, the Kaiser Permanente Bernard J. Tyson School of Medicine welcomed its inaugural class.
In this INNOVATORS, Dr. Schuster answers the why, how, and so what of launching a new medical school.
INNOVATORS is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on INNOVATORS do not necessarily reflect the views of the interviewee's institution or organization.*
Data Science and the Study of Alzheimer's (with Christopher Gaiteri, PhD, Associate Professor of Psychiatry & Behavioral Sciences; Empire Innovation Scholar, SUNY Upstate Medical University)
2023/07/05
Christopher Gaiteri, Ph.D., is Associate Professor of Psychiatry & Behavioral Sciences and Empire Innovation Scholar at SUNY Upstate Medical University. Dr. Gaiteri earned his undergraduate degree from Washington & Lee University and his doctorate from the University of Pittsburgh. He joined Rush University as assistant professor of neurological sciences and computational neuroscientist after serving as Research Scientist at the Allen Institute for Brain Science and Senior Scientist at Sage Bionetworks.
In today's podcast, Dr. Gaiteri responds to the following questions:
1. What were the origins to your approach and how does it differ from the more traditional way of framing research about the onset and development of Alzheimer's disease?
2. Statistical techniques such as factor analysis and canonical correlation were used in research to take a large number of measures of variables and allow those statistical techniques to sort out which of those variables covaried and which patterns emerged that could suggest relationships to be looked at more closely.
In your approach using "big data" do you have a particular notion of which variables you select ought to covary? In other words, do you have a "pre-theory" that guides your selection of variables?
3. Alzheimer's is nearly always associated with the aging process, perhaps implicitly arguing that the aging process alone is a causal agent for the onset and progression of the disease. More recently and not without some controversy, some researchers have suggested that aging itself should be considered a disease. From your perspective, does the question of age influence your view on how to go about framing analyses of data bearing on the inception and development of Alzheimer's?
4. In your career to date, how has the leadership of organizations in which you have worked influenced you and your research? Are there characteristics of persons who hold leadership roles that you single out as especially important to your work?
INNOVATORS is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on INNOVATORS do not necessarily reflect the views of the interviewee's institution or organization.*
The Development and Evolution of Data Science: Potential and Leadership (with Philip E. Bourne, Ph.D., Founding Stephenson Dean, School of Data Science and Professor of Biomedical Engineering, University of Virginia)
2023/01/17
Dr. Philip Bourne, founding Stephenson Dean of the School of Data Science at the University of Virginia, established in 2019 with a gift of $120 million. Dr. Bourne's career encompasses work at Columbia University, the University of California at San Diego, and the National Institutes of Health and includes motorcycle jaunts throughout western Virginia and beyond. We spoke with him at his office in Charlottesville about the following (abridged version of) questions:
1. Why a separate school of data science?
2. What gives data science its coherence as a professional field and an academic discipline? Does that include tackling a set of "grand challenges" such as we see in, for example, engineering?
3. Your school is described as one "without walls," suggesting perhaps a virtual format for learning. How will students, including working professionals you identify as persons you seek to serve, learn in the school?
4. Is there any reason to expect student enrollment and degree completion in data science to be any different in terms of representation of persons of color? Will students be taught by a diverse data science faculty? If so, why?
5. What do you see as the other key attributes, experiences, and expertise of someone who can lead successfully an academic leadership position in data science?
INNOVATORS is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on INNOVATORS do not necessarily reflect the views of the interviewee's institution or organization.*
Pushing the Boundaries of What's Possible in Children's Health: Breakthroughs & Beyond (with Carlos R. Estrada Jr., MD)
2022/11/01
Over the past year, several INNOVATORS were devoted to learning more about the state of pediatric research. In this podcast, we learn about a breakthrough in the development of tissue from silk for use in the treatment of children born with spinal bifida.
Dr. Carlos Estrada holds appointments at Boston Children's Hospital and Harvard Medical School and was instrumental in the development and use of a new type of tissue. He earned his undergraduate degree from College of the Holy Cross and the MD from Wright State University Boonshoft School of Medicine. He completed an internship and residencies at Rush University Medical Center, then accepted a fellowship at Boston Children's Hospital from which he accepted an appointment to the faculty there. He earned an MBA from MIT. He focuses his research on tissue engineering and neurogenic bladder dysfunction.
In today's podcast, he responds to the following questions:
Describe the work you and your colleagues have been engaged in, particularly the rationale for pursuing it as well as its significance for the treatment of children? Since launching INNOVATORS nearly 5 years ago, we've encountered several instances in a variety of fields including veterinary medicine and prosthetics, to mention only two, where the search for material that might be a substitute for surface skin was the "holy grail". Your work seems to open up a much broader spectrum of applications. What are some of those and are the applications direct and straightforward or do they entail more research? The announcement of your breakthrough was attended by an emphasis on the importance of collaboration that transcended areas of specialization and perhaps even entire fields. Who/what were those other partners and how did the collaboration come about and how was it sustained? Specifically, what role did leadership, on the part of an individual or a group of decision makers, play in facilitating collaboration? The kind of research you and colleagues have been involved with requires resources. What kinds and which sources of resources were instrumental in advancing your research? Finally, even as you revel in what your research has accomplished, do you look out beyond the more immediate uses of your findings to applications that have become a bit more feasible precisely because of what the research makes possible now? What are some of those? INNOVATORS is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on INNOVATORS do not necessarily reflect the views of the interviewee's institution or organization.*
Data Science: Academia's Newest and Fastest-Growing Field (with Dr. Talitha Washington, Professor of Mathematics and the Director of the Atlanta University Center Data Science Initiative)
2022/10/04
Dr. Talitha Washington is Professor of Mathematics and the Director of the Atlanta University Center Data Science Initiative.
On leave to the National Science Foundation, she received the NSF Director's Award for Superior Accomplishment in 2020 "for exceptional stewardship in establishing the first NSF Hispanic-serving Institution program." She is a graduate of Spelman College and earned her Ph.D. from the University of Connecticut, then completed a research post-doctorate at Duke University.
The Atlanta University Center Data Science Initiative is a unique collaboration among four historically black colleges and universities (Clark Atlanta University, Morehouse College, Morehouse School of Medicine, and Spelman College) aiming to infuse data science within and across each institution, and led by its Director, Dr. Washington, who responded to these questions:
How did the four institutions of the consortium come together to seek to establish a data science initiative and why? What is the scope of the AUC Data Science Initiative and what outcomes are being pursued? You and your staff are tasked with integrating data science into and across the curricula of four separate institutions and therefore have to know how courses and curricula are made. How do you go about making change take place? Moreover, aren't you also changing faculty? As a mathematician and data scientist yourself, it seems likely that you have looked at data on the relative success of cross-institutional, multi- and inter-disciplinary curricular and instruction initiatives such as you are directing. What do the data tell you? A final question is prompted by good news for you and your colleagues. The National Science Foundation announced that Clark Atlanta University will be awarded a $10 million grant to establish the National Data Science Alliance. The new Alliance will extend the University's efforts to expand participation in data science to the nation's HBCU institutions and increase the numbers of credentialed Black data scientists. As the new Alliance's principal investigator, tell us what is the scale of this effort? How many more institutions will be involved and what do you aim to accomplish in terms of additional student data scientists?
Innovators is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on Innovators do not necessarily reflect the views of the interviewee's institution or organization.*
For additional insights on data science, see previous INNOVATORS podcasts:
Digital Health – Technological and Scientific Invention and Innovation in Healthcare;
The Burgeoning and Expanding Field of Data Science; and Artificial Intelligence and Precision Medicine.
Fertile Times in Materials Science: A Conversation with Dr. David Kaplan
2022/09/20
David Kaplan is Distinguished Professor and Stern Family Professor of Engineering and Chair of Biomedical Engineering at Tufts University and was recently elected to the National Academy of Engineering.
Research is achieving major breakthroughs in tissue growth, cellular agriculture, medical implants, new ways to store electricity and deal with plastic waste. The time is right for a brief conversation with a leading researcher in materials science, so we asked Dr. Kaplan:
What have been the primary accelerators of discovery, innovation, and invention in materials science during your career? Which are the principal "engines" producing new knowledge in materials science – universities, large governmental and non-governmental laboratories, or industry? The interdisciplinary nature of materials science research is quite remarkable: How did that feature come about? What are the attributes of administrators and executives that make for effective leadership to enable solid research in materials science? What does the near-term future hold in terms of new advances in materials science?
Continuing to direct a large research laboratory while chairing a major program in medical engineering, Dr. Kaplan speaks with wit, pride, and humility about a field pushing its boundaries in a multitude of directions with remarkable results already affecting important change.
Innovators is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on Innovators do not necessarily reflect the views of the interviewee's institution or organization.*
Climate Change & Actionable Scientific Research: A Conversation with Dr. James Arnott, Executive Director of the Aspen Global Change Institute
2022/08/30
While the dispute over the causes and sources of climate change continues, few doubt the need for action to deal with the consequences of climate change. And action can best be guided by findings from solid scientific research.
James Arnott, Ph.D. makes the case that science can contribute to not only policy but action. But for that to occur, science will need to be more transparent and inclusive to meet the challenge of coping with the effects of climate change.
Dr. Arnott earned his doctorate in Environment and Sustainability from the University of Michigan and a B.A. in Political Science and Economics from Principia College. His research explores how science can become more actionable for decision making. This involves studying how different approaches to collaboration, science translation, and funding can influence how research becomes used and to what end.
Listen to his comments and responses to the following questions:
Is it too cynical to argue that the failure to marshal collective efforts to deal with climate change is a matter of politics and economics, not science; that there are vested interests for maintaining the status quo, not challenges to research or the scientific method? Is it the case that even the very best science being devoted to climate change struggles to be interpreted in terms lay persons and governmental officials can comprehend fully? What is "actionable science"? How does it differ from what scientists do now and with what effect? Do you view it as something akin to what Thomas Kuhn termed a "paradigm shift" in science? If actionable science calls for researchers who either have experience with and/or understand the perspectives of those persons to whom the scientific results are presented, how might ways change in order to prepare the next generation of scientists? Actionable research in the contexts of achieving community, national, and global sustainability is compelling in many respects. How does adopting such an approach influence the attributes of those persons who lead scientific centers and laboratories with emphases on climate change? Innovators is a podcast production of Harris Search Associates.
*The views and opinions shared by the guests on Innovators do not necessarily reflect the views of the interviewee's institution or organization.*
Podcast sponsorship advertising
Start advertising on Innovators relevant audience podcasts
You may also like to advertise on these Podcasts

4.76763467
Criminology
Emash Digital & Mike Ferguson, Mike Morford

4.87554989
The Dr. John Delony Show
Ramsey Network

4.512669676
RedHanded
RedHanded

4.959992000
Legal AF by MeidasTouch
MeidasTouch Network

4.7292862000
The Michael Knowles Show
The Daily Wire

4.930912000
The Quote of the Day Show | Daily Motivational Talks
Sean Croxton

4.7278962000
The Matt Walsh Show
The Daily Wire

4.9248151467
Unashamed with the Robertson Family
Tread Lively

4.897071458
The Graham Allen Show
Graham Allen

4.7106622000
FantasyPros - Fantasy Football Podcast
iHeartPodcasts